HSP60 peptide treatment of Type 1 Diabetes: translating a basic observation into a successful phase 3 clinical trial.
Nov 13, 2012 (Tue) | 4:15 PM -5:15 PM
Alway M106
: Stanford, CA
Department: Immunology
Contact: Nicki Barnes | 6-1980 | nbarnes@stanford.edu
Presenter(s):
- Irun Cohen Weizmann Institute of Science